UNM doctors treat first COVID-19 patient with experimental therapy

Coronavirus New Mexico

ALBUQUERQUE, N.M. (KRQE) – University of New Mexico doctors are treating the first COVID-19 patient to get a new experimental drug. UNM says the drug is for severe cases where patients suffer from acute breathing and kidney problems. The new drug therapy is supposed to drive down life-threatening inflammation in the body.

“We’re using stem cell therapy to counteract an overactive immune system that is definitely a part of the COVID disease,” said Pedro Teixeria, assistant professor at the Department of Internal Medicine at UNM Hospital.

Sentien Biotechnologies, out of Massachusetts, developed the drug; The first COVID-19 patient to be treated with it right here in New Mexico is now enrolled in a clinical trial to study its effects.

Copyright 2021 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Latest Video

Now Trending on KRQE.com

New Mexico Hourly Forecasts ⟶

Albuquerque Hourly Forecast

Don't Miss

MORE IN DON'T MISS

Photo Galleries

MORE PHOTO GALLERIES

News Resources - Maps

MORE NEWS RESOURCES